Cloned (Comment) | Organism |
---|---|
expression in Escherichia coli | Homo sapiens |
expression in Escherichia coli | Rattus norvegicus |
Crystallization (Comment) | Organism |
---|---|
- |
Homo sapiens |
- |
Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-ethyl-7-(3-hydroxy-3-methylpyrrolidin-1-yl)-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | - |
Homo sapiens | |
3-(trifluoromethyl)quinoxalin-2(1H)-one | - |
Homo sapiens | |
4,6-dimethyl-2-(morpholin-4-yl)pyridine-3-carbonitrile | - |
Homo sapiens | |
6-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | nonbasic moderately potent and highly selective ketohexokinase inhibitor | Homo sapiens | |
6-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | nonbasic moderately potent and highly selective ketohexokinase inhibitor with favorable ADME and safety profiles and good exposure in rats | Rattus norvegicus | |
6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | - |
Homo sapiens | |
6-[4-(2-hydroxyethyl)piperazin-1-yl]-4-[3-(hydroxymethyl)piperidin-1-yl]-2-(trifluoromethyl)pyridine-3-carbonitrile | - |
Homo sapiens | |
7-[(3R)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | - |
Homo sapiens | |
7-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | - |
Homo sapiens | |
7-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | - |
Rattus norvegicus | |
[(3R)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]methanol | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P50053 | - |
- |
Rattus norvegicus | Q02974 | - |
- |
Purification (Comment) | Organism |
---|---|
- |
Homo sapiens |
- |
Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + D-fructose | - |
Homo sapiens | ADP + D-fructose 1-phosphate | - |
? | |
ATP + D-fructose | - |
Rattus norvegicus | ADP + D-fructose 1-phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
KHK | - |
Homo sapiens |
KHK | - |
Rattus norvegicus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00039 | - |
23°C, pH 7.4, splice variant KHK-A | Homo sapiens | 6-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | |
0.00045 | - |
23°C, pH 7.4, splice variant KHK-C | Homo sapiens | 6-[(3S,4S)-3,4-dihydroxypyrrolidin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | |
0.00064 | - |
23°C, pH 7.4 | Rattus norvegicus | 7-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | |
0.00067 | - |
23°C, pH 7.4 | Homo sapiens | 7-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | |
0.00103 | - |
23°C, pH 7.4 | Homo sapiens | 6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-[(3S)-3-hydroxy-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | |
0.00148 | - |
23°C, pH 7.4 | Homo sapiens | 2-ethyl-7-(3-hydroxy-3-methylpyrrolidin-1-yl)-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | |
0.01679 | - |
23°C, pH 7.4 | Homo sapiens | 6-[4-(2-hydroxyethyl)piperazin-1-yl]-4-[3-(hydroxymethyl)piperidin-1-yl]-2-(trifluoromethyl)pyridine-3-carbonitrile | |
0.02421 | - |
23°C, pH 7.4 | Homo sapiens | 7-[(3R)-3-hydroxy-3-methylpyrrolidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile | |
0.1 | - |
23°C, pH 7.4 | Homo sapiens | 3-(trifluoromethyl)quinoxalin-2(1H)-one | |
0.118 | - |
23°C, pH 7.4 | Homo sapiens | [(3R)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]methanol | |
0.319 | - |
23°C, pH 7.4 | Homo sapiens | 4,6-dimethyl-2-(morpholin-4-yl)pyridine-3-carbonitrile |
General Information | Comment | Organism |
---|---|---|
metabolism | increased fructose consumption and its subsequent metabolism are implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance | Homo sapiens |
metabolism | increased fructose consumption and its subsequent metabolism are implicated in hepatic steatosis, dyslipidemia, obesity, and insulin resistance | Rattus norvegicus |